301: Ignite Session 1A

Presentations:

• 1:00 PM – 1:05 PM Eastern Time

  Associations Between Fatty Acid Amide Hydrolase Variants and Response to Cannabis Use for Pain Management in Rheumatoid Arthritis
  

  Ignite Speaker: Kristin Wipfler, PhD – FORWARD, The National Databank for Rheumatic Diseases
• 1:05 PM – 1:10 PM Eastern Time

  Mitochondrial Content in Skeletal Muscle of Individuals with Rheumatoid Arthritis Is Associated with Physical Activity Level
  

  Ignite Speaker: Beatriz Hanaoka, MD, MSc – OSU
• 1:10 PM – 1:15 PM Eastern Time

  Practical Cut-off Points for Using the Rheumatoid Arthritis Impact of Disease (RAID) Questionnaire in Remote Consult Triage
  

  Ignite Speaker: Angelique Weel, MD – Maasstad Hopsital & Erasmus University
• 1:15 PM – 1:20 PM Eastern Time

  Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis
  

  Ignite Speaker: Joshua Baker, MD, MS – University of Pennsylvania
• 1:20 PM – 1:25 PM Eastern Time

  Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort
  

  Ignite Speaker: Signe Møller-Bisgaard, MD, PhD – Rigshospitalet, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases
• 1:25 PM – 1:30 PM Eastern Time

  DAS28-gGT for the Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort
  

  Ignite Speaker: Anne Dupont, MD – Cochin Hospital
• 1:30 PM – 1:35 PM Eastern Time

  Effect of Biologic Agents on Lipid Levels and Cardiovascular Risk in Rheumatoid Arthritis Patients
  

  Ignite Speaker: Dimitrios Pappas, MD, MPH – CorEvitas
• 1:35 PM – 1:40 PM Eastern Time

  The Impact of Disease Activity on Patient-Reported Cognitive Dysfunction in Rheumatoid Arthritis
  

  Ignite Speaker: Ozlem Pala, MD, MPH – University of Miami
• 1:40 PM – 1:45 PM Eastern Time

  Relationship Between Disease Activity and Adverse Events of Interest in Patients with RA on Tofacitinib or TNF Inhibitors: Post Hoc Analysis of a Phase 3b/4 Randomized Safety Study
  

  Ignite Speaker: George A. Karpouzas, MD – Harbor-UCLA Medical Center
• 1:45 PM – 1:50 PM Eastern Time

  Integrative Multi-omic Phenotyping in Blood Identifies Molecular Signatures and Candidate Biomarkers of ACPA-negative Rheumatoid Arthritis
  

  Ignite Speaker: Benjamin Hur, PhD – Mayo Clinic